Further to its letters dated February 8, 2023, March 28, 2023 and July 27, 2023, Piramal Pharma has informed that it enclosed copies of advertisement issued by the Company today, 24th August, 2023, in respect of matters specified under subregulation (1) of Regulation 92 of SEBI ICDR Regulations, in all editions of Financial Express (English national daily newspaper with wide circulation), Jansatta (Hindi national daily newspaper with wide circulation), and Navshakti (Marathi being the regional language in the place where its Registered and Corporate Office is located).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: